NRG-BR002 Published in JCO
For Breast Cancer Awareness Month, we discuss the results of the NRG-BR002 in newly oligometastatic breast cancer published in the Journal of Clinical Oncology today.
7 Okt 13min
NRG-HN009 p16-Negative Results at ASTRO 2026
We discuss the reported results of the NRG-HN009 p16-negative cohort presented at the ASTRO Annual Meeting Late-Breaking Abstract Session.
29 Sep 13min
NRG-CC009 and the MAVERICK Study at ASTRO 2026
We discuss both the NRG-CC009 study results presented during the 2026 ASTRO Annual Meeting Plenary Session and the MAVERICK study results presented during the Clinical Trials Session.
28 Sep 21min
NRG-GI003 Results in the ASTRO 2026 Plenary
We discuss the NRG-GI003 results presented during the 2026 ASTRO Annual Meeting Plenary Session.
28 Sep 14min
The SPPORT Study Analysis Results at ASTRO 2026
We interview Dr. Shang "George" Zhao on the NRG-RTOG 0534 "SPPORT" study results he presented at the 2026 ASTRO Annual Meeting Clinical Trials Session.
27 Sep 11min
The NRG-GY036 Trial for Ovarian Cancer Month
For the 2026 Ovarian Cancer Month & Gynecologic Cancer Month, we discuss the currently enrolling NRG-GY036 clinical trial comparing 1 vs. 2 years of maintenance olaparib (with or without bevacizumab) ...
4 Sep 23min
NRG-HN016: The "CONCISE" Study for Locoregionally Advanced Head and Neck Cancer Patients that are Unable to Take Cisplatin
Our co-hosts interview the PI of the active NRG-HN016 (CONCISE) trial, Dr. Loren Mell. The CONCISE study is a randomized phase III trial comparing radiation therapy (RT) plus carboplatin/paclitaxel vs...
13 Aug 17min
